atazanavir sulfate has been researched along with emtricitabine, tenofovir disoproxil fumarate drug combination in 4 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (emtricitabine, tenofovir disoproxil fumarate drug combination) | Trials (emtricitabine, tenofovir disoproxil fumarate drug combination) | Recent Studies (post-2010) (emtricitabine, tenofovir disoproxil fumarate drug combination) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 254 | 31 | 213 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhatti, L; Conner, C; Dejesus, E; Mills, A; Storfer, S | 1 |
Ferretti, F; Mora-Peris, B; Stevens, E; Taylor, S; Underwood, J; Winston, A | 1 |
Chmielinska, JJ; ElZohary, L; Kramer, JH; Mak, IT; Weglicki, WB | 1 |
2 trial(s) available for atazanavir sulfate and emtricitabine, tenofovir disoproxil fumarate drug combination
Article | Year |
---|---|
A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lipid Metabolism; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphorus Compounds; Pyridines; Ritonavir; Treatment Outcome; Viral Load; Young Adult | 2011 |
Evolution of changes in cognitive function after the initiation of antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cognition; Cognition Disorders; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Male; Middle Aged; Neuropsychological Tests; Nevirapine; Ritonavir; Young Adult | 2016 |
2 other study(ies) available for atazanavir sulfate and emtricitabine, tenofovir disoproxil fumarate drug combination
Article | Year |
---|---|
Single-tablet Quad regimen achieves high rate of virologic suppression.
Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Clinical Trials, Phase II as Topic; Cytochrome P-450 CYP3A Inhibitors; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV-1; Humans; Multicenter Studies as Topic; Oligopeptides; Organophosphonates; Organophosphorus Compounds; Oxazines; Pyridines; Quinolones; Randomized Controlled Trials as Topic; Ritonavir; Treatment Outcome; Viral Load | 2010 |
Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats.
Topics: Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Dietary Supplements; Disease Models, Animal; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Gene Expression Regulation; HIV Infections; HIV-1; Humans; Lipogenesis; Liver; Magnesium; Male; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Inbred F344; Rats, Transgenic; Ritonavir | 2019 |